ARCHIVES

Guest Editorial: Andrew Vickers on PSA Skepticism, Rational and Irrational

This article is from The Cancer Letter archive.

Vol. 40 No. 38 | October 10, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

February 17, 1989

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

April 24, 1998

Tivozanib Does Not Improve OS Compared to Sorafenib

February 22, 2013

NCI, Dept. of Veteran’s Affairs Sign Agreement On Clinical Trials Access

November 1, 1996

Atlas Showing County Cancer Rates Available

July 18, 1975

Blistering Resignation Letters Declare CPRIT Outside Mainstream of Science

October 12, 2012